AdvisorShares Investments’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

AdvisorShares Investments’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.11M	Sell	32,883 -3,548	-10%	-$118K	0.13%	81
2026 Q1	$1.1M	Sell	36,431 -369	-1%	-$11.9K	0.2%	73
2025 Q4	$1.15M	Buy	+36,800	New	+$907K	0.19%	72
2025 Q2	–	Sell	-43,182	Closed	-$660K	–	332
2025 Q1	$660K	Buy	43,182 +14,486	+50%	+$259K	0.13%	87
2024 Q4	$632K	Sell	28,696 -4,220	-13%	-$76.8K	0.12%	72
2024 Q3	$593K	Buy	+32,916	New	+$576K	0.11%	75

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

AdvisorShares Investments's TEVA Position: Q2 2026 in Review

AdvisorShares Investments reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 9.7% in Q2 2026, selling an estimated $118K and leaving 32,883 shares worth $1.11M. The position accounts for 0.13% of the portfolio, ranked #81.

AdvisorShares Investments first reported a position in TEVA in Q3 2024 and has held it in 6 quarters since. The position peaked at $1.15M in Q4 2025. 677 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

AdvisorShares Investments held 32,883 shares of Teva Pharmaceutical Industries Limited worth $1.11M as of Q2 2026.
AdvisorShares Investments sold 3,548 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $118K.
Teva Pharmaceutical Industries Limited made up 0.13% of AdvisorShares Investments's portfolio in Q2 2026, its #81 holding.
AdvisorShares Investments first reported a position in Teva Pharmaceutical Industries Limited in Q3 2024 and has held it in 6 quarters since.
AdvisorShares Investments's Teva Pharmaceutical Industries Limited position peaked at $1.15M in Q4 2025.
677 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on AdvisorShares Investments's 13F filing for Q2 2026, filed 11 Aug 2026.